Currently active FOAs for neuroscience research include the following Requests for Applications (RFAs), Program Announcements (PAs), and PAs with special reviews (PARs) and NOTs.
FOAs on which the NICHD is the primary sponsor
- RFA-HD-20-002 Pediatric HIV/AIDS Cohort Study (PHACS): 2020 (P01 Clinical Trial Not Allowed)
- RFA-HD-20-008 Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed)
- RFA-HD-20-006 U.S. Children with Perinatal HIV who were Born Internationally (R01 Clinical Trial Optional)
- RFA-HD-20-020 Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
- PA-18-839 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and without HIV (R21 Clinical Trial Optional)
- PA-18-838 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and without HIV (R01 Clinical Trial Optional)
- PAR-18-831 The Role of Epitranscriptomics in Development and Disease (R21 Clinical Trial Not Allowed)
- PAR-18-830 The Role of Epitranscriptomics in Development and Disease (R01 Clinical Trial Not Allowed)
- PAR-18-766 Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 Clinical Trial Optional)
- PAR-18-691 Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional)
- PAR-18 690 Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional)
- PAR-18-689 Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 Clinical Trial Optional)
- PAR-18-215 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
- PAR-18-214 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
- PA-18-049 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)
- PA-18-044 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
- PA-18-043 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
- PA-18-038 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
- PAR-17-454 Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
- PA-17-262 Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
- PAR-17-236 Genetic Susceptibility & Variability of Human Structural Birth Defects (R01)
- PAR-17-188 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)
- PA-17-091 Fertility Status as a Marker of Overall Health (R01)
- PAR-17-005 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
FOAs on which the NICHD is a partner institute
- PAR-18-822 Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
- PAR-19-376 Mobile Health: Technology and Outcomes in Low and Middle income Countries (R21/R33 Clinical Trial Optional)
- PAR-19-158 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- RFA-NS-19-031 Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
- PAR-18-836 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
- PAR-18-835 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)
- PA-18-720 Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
- PA-18-401 Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
- PA-18-400 Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
- PA-18-399 Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
- PA-18-328 Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21 Clinical Trial Optional)
- PAR-18-324 Testing Interventions for Health-Enhancing Physical Activity (R01 Clinical Trial Optional)
- PA-18-316 Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01 Clinical Trial Optional)
- PAR-18-205 NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)
- RFA-NS-18-041 Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
In addition, the NICHD is also involved in the active FOAs related to the NIH Blueprint for Neuroscience Research.
BACK TO TOP